BNIP3P7

Across TCGA pan-cancer cohorts, BNIP3P7 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated BNIP3P7 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher BNIP3P7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated BNIP3P7 expression acts as an unfavorable survival marker.

UCEC, KIRC, and THCA are the cancer types where BNIP3P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.487	0.876	<.001	66	view →
KIRC	DFS	Tertile	All	0.162	0.636	<.001	54	view →
THCA	DFS	Tertile	All	0.716	0.861	<.001	49	view →
COAD	OS	Tertile	IV	0.045	0.659	<.001	36	view →
THYM	DFS	Tertile	II,III,IV	0.172	0.747	.005	36	view →
CHOL	OS	Tertile	All	0.168	0.742	<.001	18	view →
SKCM	DFS	Tertile	IV	0.016	0.454	<.001	18	view →
LAML	DFS	Tertile	All	0.028	0.583	.001	18	view →
LUSC	OS	Tertile	All	0.624	0.780	.029	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

BNIP3P7–UCEC (OS)

Open the UCEC breakdown →